Article
Toxicity Management in CAR T cell therapy for B-ALL: Mathematical modelling as a new avenue for improvement
2016-04-22
Abstract excerpt
Advances in genetic engineering have made it possible to reprogram individual immune cells to express receptors that recognise markers on tumour cell surfaces. The process of re-engineering T cell lymphocytes to express Chimeric Antigen Receptors (CARs), and then re-infusing the CAR-modified T cells into patients to treat various cancers is referred to as CAR T cell therapy. This therapy is being explored in clin...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 628aa109-b24b-5c82-84be-56f7da98547d
- DOI
- 10.1101/049908
